Martin Shkreli appears in federal court over financial irregularities (5 images)

Turing Pharmaceuticals CEO Martin Shkreli was arrested in December for alleged financial irregularities. Shkreli drew fire for boosting the price of Daraprim, a drug used to treat infections that are found in those with compromised immune systems, by 4,000 percent.

Turing Pharmaceuticals CEO Martin Shkreli arrives at the United States Federal courthouse on February 3, 2016 in New York City. Photo by John Angelillo/UPI

License photo | Permalink

---

---

Turing Pharmaceuticals CEO Martin Shkreli and attorney Benjamin Brafman arrive at the United States Federal courthouse on February 3, 2016 in New York City. Photo by John Angelillo/UPI

License photo | Permalink

---

---

Turing Pharmaceuticals CEO Martin Shkreli arrives at the United States Federal courthouse on February 3, 2016 in New York City. Photo by John Angelillo/UPI

License photo | Permalink

---

---

Turing Pharmaceuticals CEO Martin Shkreli and attorney Benjamin Brafman arrive at the United States Federal courthouse on February 3, 2016 in New York City. Photo by John Angelillo/UPI

License photo | Permalink

---

---